"They're talking about pain at the $3 billion California stem cell agency. And mortality. But not the end of life as you and I know it.
"They're talking about the pain that comes from cutting off millions of dollars for scientists. They're talking about what will happen when the state stops borrowing money to finance stem cell research – a final-breath moment that arrives in about five years....
"CIRM's changing priorities create 'stark tension,' said one board member, Michael Friedman, CEO of the City of Hope in the Los Angeles area, in January. 'We're going to have to make some really painful and difficult decisions,' he told directors.
"CIRM's success – or lack of it – will play a critical role in its future finances, whether they are based on another bond measure or private support."Sphere: Related Content